A (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP of the European Pharmacopoeia monograph is often referred to as a (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Certificate of Suitability (COS). The purpose of a (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol to their clients by showing that a (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP has been issued for it. The manufacturer submits a (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP (COS) as part of the market authorization procedure, and it takes on the role of a (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP holder for the record. Additionally, the data presented in the (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol DMF.
A (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol suppliers with CEP (COS) on PharmaCompass.